In the last trading session, 5.75 million Vaxart Inc (NASDAQ:VXRT) shares changed hands as the company’s beta touched 1.25. With the company’s per share price at $0.51 changed hands at $0.09 or 18.99% during last session, the market valuation stood at $115.28M. VXRT’s last price was a discount, traded about -109.8% off its 52-week high of $1.07. The share price had its 52-week low at $0.28, which suggests the last value was 45.1% up since then.
Analysts gave the Vaxart Inc (VXRT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended VXRT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Vaxart Inc’s EPS for the current quarter is expected to be -0.11.
Vaxart Inc (NASDAQ:VXRT) trade information
Instantly VXRT was in green as seen at the end of in last trading. With action 20.38%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -23.71%, with the 5-day performance at 20.38% in the green. However, in the 30-day time frame, Vaxart Inc (NASDAQ:VXRT) is 44.77% up.
The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need an upside of 74.5% from its current market value. According to analyst projections, VXRT’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a -292.16% plunge from its current level, while the stock would need to soar -292.16% for it to hit the projected low.
Vaxart Inc (VXRT) estimates and forecasts
Year-over-year growth is forecast to reach -15.85% down from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 1.09M. 2 analysts are of the opinion that Vaxart Inc’s revenue for the current quarter will be 1.09M. The company’s revenue for the corresponding quarters a year ago was 6.4M and 4.93M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -83.01%. The estimates for the next quarter sales put growth at -77.95%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.46%. The 2025 estimates are for Vaxart Inc earnings to increase by 12.12%, but the outlook for the next 5-year period is at -15.99% per year.
VXRT Dividends
Vaxart Inc is expected to release its next quarterly earnings report in June.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 5.3875% or 9.95 million shares worth $6.64 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 7.16 shares estimated at $3.62 million under it, the former controlled 3.14% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.11% of the shares, roughly 2.52 shares worth around $1.27 million.
